Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-26-000022
Filing Date
2026-04-21
Accepted
2026-04-21 16:03:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A ligand-2026proxysupplement.htm DEFA14A 9733
2 newligandlogo.jpg GRAPHIC 43732
3 noticecard2of2.jpg GRAPHIC 199526
4 noticecard_1of2.jpg GRAPHIC 211926
  Complete submission text file 0000886163-26-000022.txt   637955
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 26879350
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)